使用本网站需要启用 JavaScript, 请启用后刷新页面获得更好的体验
登录
注册
首页
个人基因检测
临床应用研究
科研合作项目
合作与服务
社区
研究所
微解读
应用
姓氏祖源
基因关系
原始数据
纯合片段
使用 WeGene 需要启用 Cookies, 请启用后刷新页面获得更好的体验
社区首页
小组
乳腺癌
乳腺癌
发起讨论
乳腺癌
26 个讨论
只看精华帖
按热门排序
按最新排序
PDL1和pd1用药容易超进展的研究
CAS9
• 最后回复
元月十号
•
2023-03-31 16:49
1110
2
• 来自相关小组
看到这个倍数 赶紧预约了Brca1/2基因检测
WeChat_119B01
• 最后回复
west
•
2021-11-09 21:22
2275
3
• 来自相关小组
乳腺癌风险高于平均6.8倍！有人超过我吗…
mo00on
• 最后回复
生气的CNTN6基因
•
2021-10-01 02:36
7266
35
• 来自相关小组
乳腺癌风险高于平均风险86%，是不是得赶紧买保险了
黑衣的CSMD3基因
• 最后回复
神秘的TP53
•
2021-04-30 20:09
5353
13
• 来自相关小组
乳腺癌11.26倍……
黄油电子羊
• 最后回复
看海的EPHB1基因
•
2020-07-03 21:57
2243
2
• 来自相关小组
关于乳腺癌的检测结果很准确的
处女的ANK2基因
• 最后回复
zhengqiang
•
2019-12-02 11:41
2658
2
• 来自相关小组
BRCA风险高于平均
zbingice
• 最后回复
个性的CBLB基因
•
2019-03-25 19:49
2996
3
• 来自相关小组
13.74倍，我这是以后肯定会得么？家里人没有得这个病的……
独立的LRP1B基因
• 最后回复
horinee
•
2019-01-09 10:46
3366
2
• 来自相关小组
到底微基因有没有检测brca1/2变异啊
yantonglan
• 最后回复
大灰狼
•
2018-07-19 10:03
4257
3
• 来自相关小组
我的基因风险是平均人群的 11.52 倍......
能睡的ABCC4基因
• 最后回复
天秤的TRPM3基因
•
2018-07-02 14:15
3729
2
• 来自相关小组
乳腺癌和银屑病风险都高。。
风流的NEB基因
• 最后回复
Maggie1990
•
2017-12-20 12:23
3445
4
• 来自相关小组
有没有针对brca1/2确切是否变异的检测啊
yantonglan
• 2017-12-19 17:24
3079
0
• 来自相关小组
乳腺癌风险值是平均值的24.21倍...
nnadbb
• 最后回复
zhengqiang
•
2017-10-30 13:50
3175
1
• 来自相关小组
健康风险和微解读中乳腺癌评估结果为何差异那么大
孔雀
• 最后回复
wuxiang
•
2017-08-17 15:31
3583
3
• 来自相关小组
乳腺癌5.87倍，怎么办
狂野的RYR3基因
• 最后回复
费力科思
•
2017-07-11 08:37
2934
1
• 来自相关小组
以下三组数据代表什么意思？这种情况是否有风险是否是高位
低调的Y染色体
• 2017-06-20 08:22
2921
0
• 来自相关小组
请问可以预测乳腺癌风险吗？
海饼干
• 2017-06-07 11:12
2734
0
• 来自相关小组
我的乳腺癌风险9.82倍.这是已经得了吗
机灵的12号染色体
• 最后回复
yaoxt
•
2017-03-08 16:25
3977
2
• 来自相关小组
我的检测报告是不是考虑摘掉乳腺了？
调皮的PER4基因
• 最后回复
榴莲好吃
•
2016-12-16 10:10
5901
17
• 来自相关小组
姚贝娜的乳腺癌是遗传性的么？
zhengqiang
• 最后回复
陈玉杰
•
2016-11-18 16:40
5877
1
• 来自相关小组
发起讨论
乳腺癌
26 个讨论
相关基因
BRCA1
位点：I4000377
位点：I4000378
位点：RS16942
位点：RS1799950
位点：RS1799966
位点：RS2227945
位点：RS4986850
位点：RS55770810
BRCA2
位点：I4000379
位点：RS11571833
位点：RS144848
位点：RS28897756
位点：RS4987117
位点：RS766173
TP53
位点：RS1042522
CASP8
位点：RS1045485
ZNF276
位点：RS1061646
VTCN1
位点：RS10754339
位点：RS10801935
位点：RS3738414
FGFR2
位点：RS11200014
位点：RS1219648
位点：RS2420946
位点：RS2981578
位点：RS2981579
位点：RS3750817
位点：RS7895676
EPCAM
位点：RS1126497
TNFSF10
位点：RS1131532
DMBT1
位点：RS11523871
位点：RS2981745
PALB2
位点：RS118203997
位点：RS118203998
位点：RS180177083
位点：RS180177084
位点：RS180177091
位点：RS180177092
位点：RS180177097
位点：RS180177098
位点：RS180177099
位点：RS180177100
位点：RS180177102
位点：RS180177103
位点：RS180177110
位点：RS180177111
位点：RS180177112
位点：RS180177116
位点：RS180177121
位点：RS180177122
位点：RS180177124
位点：RS180177126
位点：RS180177127
位点：RS249954
CYP2C19
位点：RS12248560
TCF7L2
位点：RS12255372
BMPR1B
位点：RS1434536
THEMIS2
位点：RS1467465
ADIPOQ-AS1
位点：RS1501299
CHEK2
位点：RS17879961
ICAM1
位点：RS1799969
ATM
位点：RS1800054
位点：RS1800056
位点：RS1800057
位点：RS1800058
位点：RS4986761
CXCL12
位点：RS1801157
NCOA3
位点：RS2230782
ADIPOQ
位点：RS2241766
LUM
位点：RS2268578
SIPA1
位点：RS2448490
XRCC1
位点：RS25489
BARD1
位点：RS28997576
CDKN1A
位点：RS3176336
CDKN2B-AS1
位点：RS3218005
XRCC2
位点：RS3218536
CDKN1B
位点：RS34330
CDKN2A
位点：RS3731239
CASC16
位点：RS3803662
SLC4A7
位点：RS4973768
CCND1
位点：RS603965
ADIPOR1
位点：RS7539542
RRP1B
位点：RS9306160
CCNE1
位点：RS997669
Johnson N, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. 2007
Bojesen SE, et al. The common germline Arg72Pro polymorphism of p53 and increased longevity in humans. 2008
Han JY, et al. Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer. 2008
Kim JG, et al. TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin. 2009
Onel KB, et al. Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults. 2009
Gaulton KJ, et al. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes. 2008
Ashton KA, et al. Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer. 2009
Chang-Claude J, et al. Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. 2009
Koshiol J, et al. Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited. 2009
Mabuchi F, et al. Lack of association between p53 gene polymorphisms and primary open angle glaucoma in the Japanese population. 2009
Sun P, et al. Association of genetic polymorphisms, mRNA expression of p53 and p21 with chronic benzene poisoning in a chinese occupational population. 2009
Hancox RJ, et al. Accelerated decline in lung function in cigarette smokers is associated with TP53/MDM2 polymorphisms. 2009
Akulevich NM, et al. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. 2009
Sinilnikova OM, et al. The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. 2009
Xian W, et al. The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube. 2010
Do TN, et al. TP53 R72P and MDM2 SNP309 polymorphisms in modification of childhood acute lymphoblastic leukemia susceptibility. 2009
Naccarati A, et al. Genotype and haplotype analysis of TP53 gene and the risk of pancreatic cancer: an association study in the Czech Republic. 2010
Ebner F, et al. The role of TP53 and p21 gene polymorphisms in breast cancer biology in a well specified and characterized German cohort. 2010
Fan BJ, et al. Association of polymorphisms of tumor necrosis factor and tumor protein p53 with primary open-angle glaucoma. 2010
Litviakov NV, et al. Association between TP53 gene ARG72PRO polymorphism and chromosome aberrations in human cancers. 2010
Tsuchiya Y, et al. Evidence that genetic variants of metabolic detoxication and cell cycle control are not related to gallbladder cancer risk in Chilean women. 2010
Ricks-Santi L, et al. p53 Pro72Arg polymorphism and prostate cancer in men of African descent. 2010
Dahabreh IJ, et al. TP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis. 2010
Ucisik-Akkaya E, et al. Examination of genetic polymorphisms in newborns for signatures of sex-specific prenatal selection. 2010
Shi JY, et al. Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia. 2011
Yoshimoto N, et al. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women. 2011
Di Vuolo V, et al. TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients. 2011
Mustafina OE, et al. [Association analysis of polymorphic loci of TP53 and NFKB1 genes with human age and longevity]. 2592
Reiling E, et al. Codon 72 polymorphism (rs1042522) of TP53 is associated with changes in diastolic blood pressure over time. 2012
Leander K, et al. NAMPT (visfatin) and AKT1 genetic variants associate with myocardial infarction. 2012
Cotignola J, et al. Investigation of the effect of MDM2 SNP309 and TP53 Arg72Pro polymorphisms on the age of onset of cutaneous melanoma. 2012
Heitzer E, et al. Infrequent p53 gene mutation but UV gradient-like p53 protein positivity in keloids. 2012
Naccarati A, et al. Mutations and polymorphisms in TP53 gene--an overview on the role in colorectal cancer. 2012
Cherdyntseva NV, et al. Crosstalk between the FGFR2 and TP53 genes in breast cancer: data from an association study and epistatic interaction analysis. 2012
Corbo RM, et al. How contemporary human reproductive behaviors influence the role of fertility-related genes: the example of the p53 gene. 2012
Azad AK, et al. Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival. 2012
Yang Y, et al. Tumor suppressor gene TP53 is genetically associated with schizophrenia in the Chinese population. 2004
Mechanic LE, et al. Polymorphisms in XPD and TP53 and mutation in human lung cancer. 2005
Zhang X, et al. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. 2006
Wu X, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. 2006
Hill DA, et al. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. 2006
Savage SA, et al. Germ-line genetic variation of TP53 in osteosarcoma. 2007
Mechanic LE, et al. Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors. 2007
Baynes C, et al. Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk. 2015
Sprague BL, et al. Genetic variation in TP53 and risk of breast cancer in a population-based case control study. 2007
Toyama T, et al. Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients. 2015
Gaudet MM, et al. Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New York. 2008
Zhu Y, et al. Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools. 2008
Rosenberger A, et al. Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years. 2008
Bittenbring J, et al. MDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians. 2008
Dai Z, et al. Genotyping panel for assessing response to cancer chemotherapy. 2008
Israni AK, et al. Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after kidney transplantation. 2008
Shi J, et al. Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. 2008
Pangilinan F, et al. Construction of a high resolution linkage disequilibrium map to evaluate common genetic variation in TP53 and neural tube defect risk in an Irish population. 2008
Tempfer CB, et al. Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. 2009
Hamaguchi M, et al. Possible difference in frequencies of genetic polymorphisms of estrogen receptor alpha, estrogen metabolism and P53 genes between estrogen receptor-positive and -negative breast cancers. 2008
Wu X, et al. Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. 2008
Lan Q, et al. Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity. 2009
Hung RJ, et al. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. 2008
Polakova V, et al. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. 2009
Hirata H, et al. Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy. 2009
Schildkraut JM, et al. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. 2009
Gallì P, et al. A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population. 2009
Kang HJ, et al. Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans. 2009
Zhou X, et al. Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: a case-control analysis. 2009
Marcel V, et al. TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis. 2009
Klug SJ, et al. TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. 2009
Scacchi R, et al. Association study between P53 and P73 gene polymorphisms and the sporadic late-onset form of Alzheimer's disease. 2009
Imboden M, et al. Decreased PM10 exposure attenuates age-related lung function decline: genetic variants in p53, p21, and CCND1 modify this effect. 2009
Daugherty CL, et al. Primary open angle glaucoma in a Caucasian population is associated with the p53 codon 72 polymorphism. 2009
Zhu F, et al. Genetic factors associated with intestinal metaplasia in a high risk Singapore-Chinese population: a cohort study. 2009
Doi N, et al. Persistence criteria for susceptibility genes for schizophrenia: a discussion from an evolutionary viewpoint. 2009
Maia AT, et al. Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast. 2009
Lee EB, et al. TP53 mutations in Korean patients with non-small cell lung cancer. 2010
Grochola LF, et al. Single-nucleotide polymorphisms in the p53 signaling pathway. 2010
Robertson LB, et al. Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation. 2010
Huang YJ, et al. A novel functional DEC1 promoter polymorphism -249T>C reduces risk of squamous cell carcinoma of the head and neck. 2010
Di Pietro F, et al. Genomic DNA extraction from whole blood stored from 15- to 30-years at -20 °C by rapid phenol-chloroform protocol: a useful tool for genetic epidemiology studies. 2011
Jha P, et al. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3. 2011
Qu L, et al. Association between polymorphisms in RAPGEF1, TP53, NRF1 and type 2 diabetes in Chinese Han population. 2011
Caamaño J, et al. TP53 codon 72 polymorphism is associated with coronary artery disease in Chilean subjects. 2011
Burgdorf KS, et al. Studies of the association of Arg72Pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55,521 Europeans. 2011
Savage SA, et al. Using epidemiology and genomics to understand osteosarcoma etiology. 2011
Srivastava K, et al. Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. 2011
Ergul E, et al. TP53 Arg72Pro polymorphism in Turkish patients with sporadic amyotrophic lateral sclerosis. 2011
Denisov EV, et al. Coordination of TP53 abnormalities in breast cancer: data from analysis of TP53 polymorphisms, loss of heterozygosity, methylation, and mutations. 2011
Liu L, et al. Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival. 2011
von Keyserling H, et al. Analysis of 4 single-nucleotide polymorphisms in relation to cervical dysplasia and cancer development using a high-throughput ligation-detection reaction procedure. 2011
Lin HY, et al. Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis. 2013
Mędrek K, et al. Association of common WRAP 53 variant with ovarian cancer risk in the Polish population. 2013
Pastor-Idoate S, et al. The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: the Retina 4 Project. 2013
Singhal P, et al. Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma. 2013
Bonfigli AR, et al. The p53 codon 72 (Arg72Pro) polymorphism is associated with the degree of insulin resistance in type 2 diabetic subjects: a cross-sectional study. 2013
Walter SD, et al. Accuracy of p53 codon 72 polymorphism status determined by multiple laboratory methods: a latent class model analysis. 2013
Chansaenroj J, et al. Polymorphisms in TP53 (rs1042522), p16 (rs11515 and rs3088440) and NQO1 (rs1800566) genes in Thai cervical cancer patients with HPV 16 infection. 2015
Son MS, et al. Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma. 2013
de Lourdes Perim A, et al. CXCL12 and TP53 genetic polymorphisms as markers of susceptibility in a Brazilian children population with acute lymphoblastic leukemia (ALL). 2013
Huang Y, et al. [Association of P53 gene polymorphisms with susceptibility to endometriosis]. 2013
Lajin B, et al. Association between polymorphisms in the genes for tumor suppressor protein p53 and its regulator NAD(P)H: quinone oxidoreductase 1 (NQO1) and schizophrenia in a Syrian study cohort. 2013
Yang J, et al. Association of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC). 2013
Ye H, et al. Genetic associations with coronary heart disease: meta-analyses of 12 candidate genetic variants. 2013
Henríquez-Hernández LA, et al. Polymorphisms in DNA-repair genes in a cohort of prostate cancer patients from different areas in Spain: heterogeneity between populations as a confounding factor in association studies. 2013
Molina E, et al. The GSTM1null (deletion) and MGMT84 rs12917 (Phe/Phe) haplotype are associated with bulky DNA adduct levels in human leukocytes. 2013
Gomes CC, et al. TP53 single nucleotide polymorphism rs1042522 in salivary gland neoplasms. 2014
Ren YW, et al. P53 Arg72Pro and MDM2 SNP309 polymorphisms cooperate to increase lung adenocarcinoma risk in Chinese female non-smokers: a case control study. 2015
Zhang H, et al. Common genetic variants in 53BP1 associated with nonsmall-cell lung cancer risk in Han Chinese. 2014
Cintra HS, et al. Investigation of genetic polymorphisms related to the outcome of radiotherapy for prostate cancer patients. 2013
Hu S, et al. The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases. 2014
Pastor-Idoate S, et al. The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy. 2013
Li Y, et al. TP53 genetic polymorphisms, interactions with lifestyle factors and lung cancer risk: a case control study in a Chinese population. 2013
Brunotto M, et al. Risk genes in head and neck cancer: a systematic review and meta-analysis of last 5 years. 2014
Huang C, et al. Genetic variants in TP53 and MDM2 associated with male infertility in Chinese population. 2012
Akbaş H, et al. Role of p53 codon 72 polymorphism in chromosomal aberrations and mitotic index in patients with chronic hepatitis B. 2012
Hao XD, et al. Correlation of telomere length shortening with TP53 somatic mutations, polymorphisms and allelic loss in breast tumors and esophageal cancer. 2013
Di Pietro F, et al. TP53*P72 allele influences negatively female life expectancy in a population of central Italy: cross-sectional study and genetic-demographic approach analysis. 2013
Thun GA, et al. The association of a variant in the cell cycle control gene CCND1 and obesity on the development of asthma in the Swiss SAPALDIA study. 2013
Wang S, et al. Effect of TP53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy. 2013
Dahabreh IJ, et al. Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer. 2013
Pineda S, et al. Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis. 2014
Mandal RK, et al. No evidence of correlation between p53 codon 72 G > C gene polymorphism and cancer risk in Indian population: a meta-analysis. 2014
Khan MH, et al. Association of the rs1042522 polymorphism with increased risk of prostate adenocarcinoma in the Pakistani population and its HuGE review. 2015
Wu GC, et al. Genetic association of single nucleotide polymorphisms in P53 pathway with gastric cancer risk in a Chinese Han population. 2015
Nowak A, et al. The relationship of TP53 and GRIN2B gene polymorphisms with risk of occurrence and progression of primary open-angle glaucoma in a Polish population. 2014
Hori Y, et al. Impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma. 2015
Cox A, et al. A common coding variant in CASP8 is associated with breast cancer risk. 2007
Shephard ND, et al. A breast cancer risk haplotype in the caspase-8 gene. 2009
Enjuanes A, et al. Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia. 2008
Ramus SJ, et al. Consortium analysis of 7 candidate SNPs for ovarian cancer. 2008
Pittman AM, et al. CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population. 2008
Couch FJ, et al. Association of breast cancer susceptibility variants with risk of pancreatic cancer. 2009
Lubahn J, et al. Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma. 2010
Srivastava K, et al. Caspase-8 polymorphisms and risk of gallbladder cancer in a northern Indian population. 2010
Campa D, et al. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. 2011
Abnet CC, et al. Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies. 2012
Pharoah PD, et al. Association between common variation in 120 candidate genes and breast cancer risk. 2007
Sigurdson AJ, et al. Polymorphisms in apoptosis- and proliferation-related genes, ionizing radiation exposure, and risk of breast cancer among U.S. Radiologic Technologists. 2007
Loza MJ, et al. Assembly of inflammation-related genes for pathway-focused genetic analysis. 2007
Li C, et al. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. 2008
Gail MH, et al. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. 2008
Smith AK, et al. Association of polymorphisms in CASP10 and CASP8 with FEV(1)/FVC and bronchial hyperresponsiveness in ethnically diverse asthmatics. 2008
Garcia-Closas M, et al. Genetic susceptibility loci for breast cancer by estrogen receptor status. 2008
Tapper W, et al. The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer. 2008
Thomas G, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). 2009
Lan Q, et al. Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies. 2009
Gaudet MM, et al. Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. 2009
Sergentanis TN, et al. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis. 2010
Mavaddat N, et al. Familial relative risks for breast cancer by pathological subtype: a population-based cohort study. 2010
Wacholder S, et al. Performance of common genetic variants in breast-cancer risk models. 2010
Grochola LF, et al. Single-nucleotide polymorphisms in the p53 signaling pathway. 2010
Travis RC, et al. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. 7610
Srivastava K, et al. Gallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes. 2011
Broeks A, et al. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. 2011
Bye H, et al. Population-specific genetic associations with oesophageal squamous cell carcinoma in South Africa. 2011
Nell EM, et al. The apoptosis pathway and the genetic predisposition to Achilles tendinopathy. 2012
Guan YP, et al. Breast cancer association studies in a Han Chinese population using 10 European-ancestry-associated breast cancer susceptibility SNPs. 1009
Rihani A, et al. CASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients. 2014
Haiman CA, et al. Comprehensive association testing of common genetic variation in DNA repair pathway genes in relationship with breast cancer risk in multiple populations. 2008
Smith TR, et al. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. 2008
Zhang J, et al. B7-H4 gene polymorphisms are associated with sporadic breast cancer in a Chinese Han population. 2009
Liu W, et al. A simple and efficient algorithm for genome-wide homozygosity analysis in disease. 2009
Ozgöz A, et al. An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer. 2013
Zhang J, et al. B7-H4 gene polymorphisms are associated with sporadic breast cancer in a Chinese Han population. 2009
Ozgöz A, et al. An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer. 2013
Hunter DJ, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. 2007
Zhao ZZ, et al. Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk. 2008
Udler MS, et al. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. 2009
Zhu X, et al. Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer. 2009
Nan H, et al. Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study. 2009
Barnholtz-Sloan JS, et al. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. 2010
Chan M, et al. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population. 2012
Zhou L, et al. Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis. 2012
Jiang L, et al. A non-synonymous polymorphism Thr115Met in the EpCAM gene is associated with an increased risk of breast cancer in Chinese population. 2011
Hu M, et al. Functional polymorphism in the EpCAM gene is associated with occurrence and advanced disease status of cervical cancer in Chinese population. 2012
Yang Y, et al. Polymorphisms of EpCAM gene and prognosis for non-small-cell lung cancer in Han Chinese. 2014
Jung JH, et al. TNF superfamily gene polymorphism as prognostic factor in early breast cancer. 2010
Van Ness B, et al. Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival. 2008
Schnabel RB, et al. The relation of genetic and environmental factors to systemic inflammatory biomarker concentrations. 2009
Tchatchou S, et al. Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity. 2010
Johnson N, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. 2007
Won HH, et al. Cataloging coding sequence variations in human genome databases. 2008
Garcia-Closas M, et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. 2013
Michailidou K, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. 2013
Wang Y, et al. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. 2014
Casadei S, et al. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. 2011
Rahman N, et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. 2007
Hofstatter EW, et al. PALB2 mutations in familial breast and pancreatic cancer. 2011
Hunter DJ, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. 2007
Zhao ZZ, et al. Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk. 2008
Raskin L, et al. FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations. 2008
Liang J, et al. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. 2008
Gates MA, et al. Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations. 2009
Rebbeck TR, et al. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. 2009
Hunter DJ, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. 2007
Zheng W, et al. Evaluation of 11 breast cancer susceptibility loci in African-American women. 2009
Chen XH, et al. Risk of aggressive breast cancer in women of Han nationality carrying TGFB1 rs1982073 C allele and FGFR2 rs1219648 G allele in North China. 2011
Long J, et al. Evaluation of breast cancer susceptibility loci in Chinese women. 2010
Li J, et al. A combined analysis of genome-wide association studies in breast cancer. 2011
Fletcher O, et al. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. 2011
Peng S, et al. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. 2011
Slattery ML, et al. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States. 2011
Teraoka SN, et al. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study. 2011
Barnholtz-Sloan JS, et al. Replication of GWAS "Hits" by Race for Breast and Prostate Cancers in European Americans and African Americans. 2011
Cherdyntseva NV, et al. Crosstalk between the FGFR2 and TP53 genes in breast cancer: data from an association study and epistatic interaction analysis. 2012
Gold B, et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. 2008
Menezes R, et al. Studies of genes in the FGF signaling pathway and oral clefts with or without dental anomalies. 2008
Montgomery GW, et al. The search for genes contributing to endometriosis risk. 2008
McGrath M, et al. Novel breast cancer risk alleles and endometrial cancer risk. 2008
Garcia-Closas M, et al. Genetic susceptibility loci for breast cancer by estrogen receptor status. 2008
Tapper W, et al. The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer. 2008
Zheng W, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. 2009
Zhu X, et al. Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer. 2009
Nan H, et al. Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study. 2009
Zhong H, et al. Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases. 2010
Saetrom P, et al. A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. 2009
Zaitlen N, et al. Leveraging genetic variability across populations for the identification of causal variants. 2010
Dickson SP, et al. Rare variants create synthetic genome-wide associations. 2010
Zhang J, et al. Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis. 2010
Jia C, et al. Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer. 2010
Zheng W, et al. Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. 2010
Barnholtz-Sloan JS, et al. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. 2010
Marian C, et al. FGFR2 intronic SNPs and breast cancer risk: associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors. 2011
Ma YP, et al. FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma. 2012
Andersen SW, et al. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study. 2013
Andersen SW, et al. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study. 2013
Jara L, et al. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population. 2013
Ozgöz A, et al. An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer. 2013
Ledwoń JK, et al. Common low-penetrance risk variants associated with breast cancer in Polish women. 2013
Liu CL, et al. Case-control study on the fibroblast growth factor receptor 2 gene polymorphisms associated with breast cancer in chinese han women. 2013
Shan J, et al. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians. 2012
Chan M, et al. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population. 2012
Küchler EC, et al. Tooth agenesis association with self-reported family history of cancer. 2013
Wang H, et al. Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk. 2013
Sim SC, et al. A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants. 2006
Schroth W, et al. Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes. 2007
Justenhoven C, et al. CYP2C19*17 is associated with decreased breast cancer risk. 2009
Santos PC, et al. CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population. 2011
Wadelius M, et al. Association of warfarin dose with genes involved in its action and metabolism. 2007
Desta Z, et al. Rapid identification of the hepatic cytochrome P450 2C19 activity using a novel and noninvasive [13C]pantoprazole breath test. 2009
Shi Y, et al. Analysis of 50 SNPs in CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP1A2 by MALDI-TOF mass spectrometry in Chinese Han population. 2011
Porcelli S, et al. Pharmacogenetics of antidepressant response. 2011
Jakovski K, et al. Characterization of the most common CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Macedonia. 2013
Suarez-Kurtz G, et al. Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin. 2012
Burns KE, et al. CYP2C19 genotype-phenotype discordance in patients with multiple myeloma leads to an acquired loss of drug-metabolising activity. 2014
Burwinkel B, et al. Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study. 2006
Scott LJ, et al. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. 2006
Lyssenko V, et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. 2007
Palmer ND, et al. Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans. 2008
Agalliu I, et al. Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study. 2008
Tabara Y, et al. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. 2009
Tong Y, et al. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. 2009
Thorsby PM, et al. Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study. 2015
Stolerman ES, et al. TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study. 2009
Goode EL, et al. No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer. 2009
Haupt A, et al. Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes. 2010
Neuman RJ, et al. Gene-gene interactions lead to higher risk for development of type 2 diabetes in an Ashkenazi Jewish population. 2010
Cruz M, et al. Candidate gene association study conditioning on individual ancestry in patients with type 2 diabetes and metabolic syndrome from Mexico City. 2010
Zampetti S, et al. Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5). 2010
Naidu R, et al. Genetic variations in transcription factor 7-like 2 (TCF7L2) gene: association of TCF7L2 rs12255372(G/T) or rs7903146(C/T) with breast cancer risk and clinico-pathological parameters. 2012
Dabelea D, et al. Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth. 2011
Gupta V, et al. Association analysis of 31 common polymorphisms with type 2 diabetes and its related traits in Indian sib pairs. 2012
Pang DX, et al. Functional analysis of TCF7L2 genetic variants associated with type 2 diabetes. 2013
Kalnina I, et al. Stronger association of common variants in TCF7L2 gene with nonobese type 2 diabetes in the Latvian population. 2012
Wang J, et al. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. 2007
Franco LF, et al. Variants of transcription factor 7-like 2 (TCF7L2) gene and incident glucose intolerance in Japanese-Brazilians. 2011
Florez JC, et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. 2006
Zhang C, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men. 2006
Damcott CM, et al. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. 2006
Cauchi S, et al. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. 2006
van Vliet-Ostaptchouk JV, et al. Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort. 2007
Chandak GR, et al. Common variants in the TCF7L2 gene are strongly associated with type 2 diabetes mellitus in the Indian population. 2007
Munoz J, et al. Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women. 2006
Marzi C, et al. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys. 2007
Mayans S, et al. TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden. 2007
Horikoshi M, et al. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population. 2007
Lehman DM, et al. Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans. 2007
Watanabe RM, et al. Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans. 2007
Hayashi T, et al. Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population. 2007
Kimber CH, et al. TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels. 2007
Scott LJ, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. 2007
Parra EJ, et al. Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City. 2007
Freathy RM, et al. Type 2 diabetes TCF7L2 risk genotypes alter birth weight: a study of 24,053 individuals. 2007
Chang YC, et al. Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population. 2007
Sale MM, et al. Variants of the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in an African-American population enriched for nephropathy. 2007
Dahlgren A, et al. Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men. 2007
Schäfer SA, et al. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. 2007
Humphries SE, et al. Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women. 2006
Salonen JT, et al. Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. 2007
Bodhini D, et al. The rs12255372(G/T) and rs7903146(C/T) polymorphisms of the TCF7L2 gene are associated with type 2 diabetes mellitus in Asian Indians. 2007
Barber TM, et al. Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS. 2007
Meigs JB, et al. Genome-wide association with diabetes-related traits in the Framingham Heart Study. 2007
Guo T, et al. TCF7L2 is not a major susceptibility gene for type 2 diabetes in Pima Indians: analysis of 3,501 individuals. 2007
Kang ES, et al. A variant of the transcription factor 7-like 2 (TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients. 2008
Huertas-Vazquez A, et al. TCF7L2 is associated with high serum triacylglycerol and differentially expressed in adipose tissue in families with familial combined hyperlipidaemia. 2008
Miyake K, et al. Association of TCF7L2 polymorphisms with susceptibility to type 2 diabetes in 4,087 Japanese subjects. 2007
Pemberton TJ, et al. Prevalence of common disease-associated variants in Asian Indians. 2008
Folsom AR, et al. Variation in TCF7L2 and increased risk of colon cancer: the Atherosclerosis Risk in Communities (ARIC) Study. 2008
Saadi H, et al. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects. 2008
Rees SD, et al. Common variants of the TCF7L2 gene are associated with increased risk of type 2 diabetes mellitus in a UK-resident South Asian population. 2008
Bielinski SJ, et al. TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the Atherosclerosis Risk in Communities (ARIC) study. 2008
Hazra A, et al. Association of the TCF7L2 polymorphism with colorectal cancer and adenoma risk. 2008
Ren Q, et al. Exon sequencing and association analysis of polymorphisms in TCF7L2 with type 2 diabetes in a Chinese population. 2008
Sanghera DK, et al. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. 2008
Köttgen A, et al. TCF7L2 variants associate with CKD progression and renal function in population-based cohorts. 2008
Alsmadi O, et al. Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population. 2008
Mahurkar S, et al. TCF7L2 gene polymorphisms do not predict susceptibility to diabetes in tropical calcific pancreatitis but may interact with SPINK1 and CTSB mutations in predicting diabetes. 2008
González-Sánchez JL, et al. Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population. 2008
Cho YM, et al. Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. 2009
Yu J, et al. Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in antiislet autoantibody-negative patients at onset of diabetes. 2009
Nordman S, et al. Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes. 2009
Warodomwichit D, et al. Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia. 2009
Cornelis MC, et al. TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women. 2009
Qi L, et al. Genetic predisposition, Western dietary pattern, and the risk of type 2 diabetes in men. 2009
Alsmadi O, et al. Specific and complete human genome amplification with improved yield achieved by phi29 DNA polymerase and a novel primer at elevated temperature. 2009
Biyasheva A, et al. Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. 2009
Mottl AK, et al. Linkage analysis of albuminuria. 2009
Raj SM, et al. No association of multiple type 2 diabetes loci with type 1 diabetes. 2009
Luo Y, et al. Meta-analysis of the association between SNPs in TCF7L2 and type 2 diabetes in East Asian population. 2009
Lappalainen S, et al. Genetic variation of FTO and TCF7L2 in premature adrenarche. 2009
Prokunina-Olsson L, et al. Tissue-specific alternative splicing of TCF7L2. 2009
Prokunina-Olsson L, et al. Alternative splicing of TCF7L2 gene in omental and subcutaneous adipose tissue and risk of type 2 diabetes. 2009
Kabagambe EK, et al. TCF7L2 polymorphisms and inflammatory markers before and after treatment with fenofibrate. 2009
Sousa AG, et al. TCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortality. 2009
Talmud PJ, et al. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. 2010
Lott L, et al. A genomics study of type 2 diabetes mellitus in U.S. Air Force personnel. 2009
Sathananthan A, et al. Personalized pharmacotherapy for Type 2 diabetes mellitus. 2009
Boccardi V, et al. Potential role of TCF7L2 gene variants on cardiac sympathetic/parasympathetic activity. 2010
Bonetti S, et al. Variants and haplotypes of TCF7L2 are associated with β-cell function in patients with newly diagnosed type 2 diabetes: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 1. 2011
Mihaescu R, et al. Genetic risk profiling for prediction of type 2 diabetes. 2011
Holstein A, et al. TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes. 2011
Muendlein A, et al. Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis. 2011
Mohan V, et al. Screening with OGTT alone or in combination with the Indian diabetes risk score or genotyping of TCF7L2 to detect undiagnosed type 2 diabetes in Asian Indians. 2011
Papadopoulou A, et al. Gestational diabetes mellitus is associated with TCF7L2 gene polymorphisms independent of HLA-DQB1*0602 genotypes and islet cell autoantibodies. 2011
Martínez-Gómez LE, et al. A replication study of the IRS1, CAPN10, TCF7L2, and PPARG gene polymorphisms associated with type 2 diabetes in two different populations of Mexico. 2011
Guinan KJ, et al. Worldwide distribution of type II diabetes-associated TCF7L2 SNPs: evidence for stratification in Europe. 2012
Yalamanchi SK, et al. Association of fibrillin-3 and transcription factor-7-like 2 gene variants with metabolic phenotypes in PCOS. 2012
Ling Q, et al. Association between donor and recipient TCF7L2 gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation in a Han Chinese population. 2013
Uma Jyothi K, et al. Association of TCF7L2 gene polymorphisms with T2DM in the population of Hyderabad, India. 2013
Wang J, et al. Association of rs12255372 in the TCF7L2 gene with type 2 diabetes mellitus: a meta-analysis. 2013
Zhang C, et al. Genetic variants and the risk of gestational diabetes mellitus: a systematic review. 2013
Peng S, et al. TCF7L2 gene polymorphisms and type 2 diabetes risk: a comprehensive and updated meta-analysis involving 121,174 subjects. 2013
Ben-Salem A, et al. Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS). 2014
Estrada-Velasco BI, et al. IRS1, TCF7L2, ADRB1, PPARG, and HHEX polymorphisms associated with atherogenic risk in Mexican population. 2013
Včelák J, et al. T2D risk haplotypes of the TCF7L2 gene in the Czech population sample: the association with free fatty acids composition. 2012
Ciccacci C, et al. TCF7L2 gene polymorphisms and type 2 diabetes: association with diabetic retinopathy and cardiovascular autonomic neuropathy. 2013
Mattei J, et al. TCF7L2 genetic variants modulate the effect of dietary fat intake on changes in body composition during a weight-loss intervention. 2012
Connor AE, et al. Associations between TCF7L2 polymorphisms and risk of breast cancer among Hispanic and non-Hispanic white women: the Breast Cancer Health Disparities Study. 2012
Nemr R, et al. Transcription factor-7-like 2 gene variants are strongly associated with type 2 diabetes in Lebanese subjects. 2012
Turki A, et al. Transcription factor-7-like 2 gene variants are strongly associated with type 2 diabetes in Tunisian Arab subjects. 2013
Shokouhi S, et al. Association of rs7903146, rs12255372, and rs290487 polymorphisms in TCF7L2 gene with type 2 diabetes in an Iranian Kurdish ethnic group. 2015
Ramos RB, et al. Association between rs7903146 and rs12255372 polymorphisms of transcription factor 7-like 2 gene and polycystic ovary syndrome: a systematic review and meta-analysis. 2015
Saetrom P, et al. A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. 2009
Feng N, et al. A miR-125b binding site polymorphism in bone morphogenetic protein membrane receptor type IB gene and prostate cancer risk in China. 2012
Johnson N, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. 2007
Healey CS, et al. A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. 2000
Agalliu I, et al. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. 2010
Bonnen PE, et al. Haplotype and linkage disequilibrium architecture for human cancer-associated genes. 2002
Sigurdson AJ, et al. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. 2004
Hill DA, et al. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. 2006
Baynes C, et al. Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk. 2015
Beesley J, et al. Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set. 2007
Ramus SJ, et al. Consortium analysis of 7 candidate SNPs for ovarian cancer. 2008
Dai Z, et al. Genotyping panel for assessing response to cancer chemotherapy. 2008
Yang H, et al. Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. 2008
Sigurdson AJ, et al. Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. 2009
Sehl ME, et al. Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer. 2009
Chang HW, et al. LD2SNPing: linkage disequilibrium plotter and RFLP enzyme mining for tag SNPs. 2009
De Leeneer K, et al. Genotyping of frequent BRCA1/2 SNPs with unlabeled probes: a supplement to HRMCA mutation scanning, allowing the strong reduction of sequencing burden. 2009
Maia AT, et al. Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast. 2009
Jiao J, et al. Occupational solvent exposure, genetic variation of DNA repair genes, and the risk of non-Hodgkin's lymphoma. 2012
Tian CQ, et al. Assessment of the Prognostic Value of Two Common Variants of BRCA1 and BRCA2 Genes in Ovarian Cancer Patients Treated with Cisplatin and Paclitaxel: A Gynecologic Oncology Group Study. 2013
Springwald A, et al. Single nucleotide polymorphisms in human gene icb-1 and breast cancer susceptibility. 2009
Kaklamani VG, et al. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. 2008
Sharma A, et al. Low serum adiponectin levels are associated with systemic organ failure in acute pancreatitis. 2009
Wang Y, et al. Association study of the single nucleotide polymorphisms in adiponectin-associated genes with type 2 diabetes in Han Chinese. 2009
Menzaghi C, et al. Circulating high molecular weight adiponectin isoform is heritable and shares a common genetic background with insulin resistance in nondiabetic White Caucasians from Italy: evidence from a family-based study. 2010
Fang WL, et al. Analysis of adiponectin gene polymorphisms in Chinese population with systemic lupus erythematosus. 2010
Chiodini BD, et al. Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population. 2010
Youpeng B, et al. Relationships among adiponectin gene polymorphisms, proteinuria and increased blood pressure in the context of placental diseases. 2010
Beebe-Dimmer JL, et al. Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans. 2010
Kaklamani V, et al. Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. 2011
Nyante SJ, et al. Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes. 2011
Lee JY, et al. Genetic effects of adiponectin single nucleotide polymorphisms on the clustering of metabolic risk factors in young Korean adults. 2012
Ranjzad F, et al. A common variant in the adiponectin gene and polycystic ovary syndrome risk. 2012
Al Khaldi RM, et al. Associations of single nucleotide polymorphisms in the adiponectin gene with adiponectin levels and cardio-metabolic risk factors in patients with cancer. 2015
Zhang BC, et al. A meta-analysis of the association of adiponectin gene polymorphisms with coronary heart disease in Chinese Han population. 2012
AlSaleh A, et al. Single nucleotide polymorphisms at the ADIPOQ gene locus interact with age and dietary intake of fat to determine serum adiponectin in subjects at risk of the metabolic syndrome. 2011
Sun K, et al. Recessive protective effect of ADIPOQ rs1501299 on cardiovascular diseases with type 2 diabetes: a meta-analysis. 2012
Oliveira CS, et al. Association of ADIPOQ variants, total and high molecular weight adiponectin levels with coronary artery disease in diabetic and non-diabetic Brazilian subjects. 2012
Xi B, et al. Common polymorphisms (rs2241766 and rs1501299) in the ADIPOQ gene are not associated with hypertension susceptibility among the Chinese. 2012
Gui MH, et al. Association of the adiponectin gene rs1501299 G>T variant, serum adiponectin levels, and the risk of coronary artery disease in a Chinese population. 2012
Pollin TI, et al. Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. 2005
Hegener HH, et al. Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: a nested case-control study. 2006
Pischon T, et al. Single nucleotide polymorphisms at the adiponectin locus and risk of coronary heart disease in men and women. 2007
Doecke JD, et al. Single nucleotide polymorphisms in obesity-related genes and the risk of esophageal cancers. 2008
Kyriakou T, et al. Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity. 2008
Simoni M, et al. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. 2008
Pérez-Martínez P, et al. Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men. 2008
Hivert MF, et al. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. 2008
Kaklamani VG, et al. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. 2008
Rasmussen-Torvik LJ, et al. The association of SNPs in ADIPOQ, ADIPOR1, and ADIPOR2 with insulin sensitivity in a cohort of adolescents and their parents. 2009
Bostrom MA, et al. Association of adiponectin gene polymorphisms with type 2 diabetes in an African American population enriched for nephropathy. 2009
Warodomwichit D, et al. ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study. 2009
Ntalla I, et al. ADIPOQ gene polymorphism rs1501299 interacts with fibre intake to affect adiponectin concentration in children: the GENe-Diet Attica Investigation on childhood obesity. 2009
Melistas L, et al. Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women. 2009
Martinez-Gomez D, et al. Design and evaluation of a treatment programme for Spanish adolescents with overweight and obesity. The EVASYON Study. 2009
Khabour OF, et al. Associations of polymorphisms in adiponectin and leptin genes with men's longevity. 2010
Chen Y, et al. Analysis of adiponectin gene polymorphisms in dilated cardiomyopathy in a Han Chinese population. 2010
Cattaert T, et al. FAM-MDR: a flexible family-based multifactor dimensionality reduction technique to detect epistasis using related individuals. 2010
Persson J, et al. Low plasma adiponectin concentration is associated with myocardial infarction in young individuals. 2010
Doria A, et al. Genetics of diabetes complications. 2010
Liu F, et al. Association of adiponectin gene polymorphisms with the risk of ischemic stroke in a Chinese Han population. 2011
Zhao T, et al. Genetic effects of adiponectin on blood lipids and blood pressure. 2011
Rodríguez-Rodríguez L, et al. Lack of association between ADIPOQ rs266729 and ADIPOQ rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients. 2011
Siitonen N, et al. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. 2011
Masson S, et al. Adiponectin in chronic heart failure: influence of diabetes and genetic variants. 2011
Han LY, et al. Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. 2011
Tsuzaki K, et al. The relationship between adiponectin, an adiponectin gene polymorphism, and high-density lipoprotein particle size: from the Mima study. 2012
Yang Y, et al. Association of ADIPOQ gene polymorphisms and coronary artery disease risk: a meta-analysis based on 12 465 subjects. 2012
Jing C, et al. Meta-analysis of association studies between five candidate genes and type 2 diabetes in Chinese Han population. 2012
Keku TO, et al. Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites. 2012
Gupta V, et al. Association of TCF7L2 and ADIPOQ with body mass index, waist-hip ratio, and systolic blood pressure in an endogamous ethnic group of India. 2012
Antonopoulos AS, et al. Genetic variability on adiponectin gene affects myocardial infarction risk: the role of endothelial dysfunction. 2013
Udomsinprasert W, et al. +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with the susceptibility to biliary atresia. 2012
Yang Y, et al. ADIPOQ gene polymorphisms and cancer risk: a meta-analysis. 2013
Ye Y, et al. Adiponectin gene polymorphisms may not be associated with idiopathic premature ovarian failure. 2013
Tong G, et al. Common variants in adiponectin gene are associated with coronary artery disease and angiographical severity of coronary atherosclerosis in type 2 diabetes. 2013
Kaklamani VG, et al. Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women's Health Initiative. 2013
Chu H, et al. AdipoQ polymorphisms are associated with type 2 diabetes mellitus: a meta-analysis study. 2013
Alsaleh A, et al. Adiponectin gene variant interacts with fish oil supplementation to influence serum adiponectin in older individuals. 2013
Cai X, et al. The adiponectin gene single-nucleotide polymorphism rs1501299 is associated with hepatocellular carcinoma risk. 2014
Machado JS, et al. Polymorphisms of the adiponectin gene in gestational hypertension and pre-eclampsia. 2014
Choe EY, et al. Variants of the adiponectin gene and diabetic microvascular complications in patients with type 2 diabetes. 2013
Gherman CD, et al. Association of atherosclerotic peripheral arterial disease with adiponectin genes SNP+45 and SNP+276: a case-control study. 2013
Hashemi M, et al. Association of Adiponectin rs1501299 and rs266729 Gene Polymorphisms With Nonalcoholic Fatty Liver Disease. 2013
Ramya K, et al. Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population. 2013
Zhang W, et al. Family-based analysis of adiponectin gene polymorphisms in Chinese Han polycystic ovary syndrome. 2014
Xu Y, et al. The roles of ADIPOQ genetic variations in cancer risk: evidence from published studies. 2013
Fan HJ, et al. Three adiponectin rs1501299G/T, rs822395A/C, and rs822396A/G polymorphisms and risk of cancer development: a meta-analysis. 2013
Kong KA, et al. Association of adiponectin gene polymorphism with birth weight in Korean neonates. 2013
Li P, et al. Correlation of serum adiponectin and adiponectin gene polymorphism with metabolic syndrome in Chinese adolescents. 2015
Tu Y, et al. Assessment of type 2 diabetes risk conferred by SNPs rs2241766 and rs1501299 in the ADIPOQ gene, a case/control study combined with meta-analyses. 2014
Lu JF, et al. Association of ADIPOQ polymorphisms with obesity risk: a meta-analysis. 2014
Johnson N, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. 2007
Cox DG, et al. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. 2011
De Leeneer K, et al. Genotyping of frequent BRCA1/2 SNPs with unlabeled probes: a supplement to HRMCA mutation scanning, allowing the strong reduction of sequencing burden. 2009
Kelsey CR, et al. Analysis of single nucleotide polymorphisms and radiation sensitivity of the lung assessed with an objective radiologic endpoin. 2013
Johnson N, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. 2007
Hung RJ, et al. Inherited predisposition of lung cancer: a hierarchical modeling approach to DNA repair and cell cycle control pathways. 2007
Brennan P, et al. Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study. 2007
Hall J, et al. The associations of sequence variants in DNA-repair and cell-cycle genes with cancer risk: genotype-phenotype correlations. 2009
Wang Y, et al. Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. 2014
Johnson N, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. 2007
Hughes L, et al. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection. 2012
Cox DG, et al. Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer. 2004
Baynes C, et al. Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk. 2015
Levin AM, et al. Chromosome 17q12 variants contribute to risk of early-onset prostate cancer. 2008
Schaid DJ, et al. Estimation of genotype relative risks from pedigree data by retrospective likelihoods. 2010
Johnson N, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. 2007
Chang JS, et al. Pathway analysis of single-nucleotide polymorphisms potentially associated with glioblastoma multiforme susceptibility using random forests. 2008
Arandi N, et al. Intercellular adhesion molecule-1 genetic markers (+241G/A and +469A/G) in Iranian women with breast cancer. 2008
Paré G, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. 2008
Albert MA, et al. Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups: data from the Women's Genome Health Study. 2009
Bielinski SJ, et al. ICAM1 and VCAM1 polymorphisms, coronary artery calcium, and circulating levels of soluble ICAM-1: the multi-ethnic study of atherosclerosis (MESA). 2008
Schnabel RB, et al. The relation of genetic and environmental factors to systemic inflammatory biomarker concentrations. 2009
Paré G, et al. On the use of variance per genotype as a tool to identify quantitative trait interaction effects: a report from the Women's Genome Health Study. 2010
Johnson DC, et al. Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma. 2011
Paré G, et al. Genome-wide association analysis of soluble ICAM-1 concentration reveals novel associations at the NFKBIK, PNPLA3, RELA, and SH2B3 loci. 2011
Hoffjan S, et al. Gene-environment interaction effects on the development of immune responses in the 1st year of life. 2005
Millstein J, et al. A testing framework for identifying susceptibility genes in the presence of epistasis. 2006
Podgoreanu MV, et al. Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery. 2006
Pullat J, et al. Optimization of candidate-gene SNP-genotyping by flexible oligonucleotide microarrays; analyzing variations in immune regulator genes of hay-fever samples. 2007
Benjamin EJ, et al. Genome-wide association with select biomarker traits in the Framingham Heart Study. 2007
Cooper JD, et al. The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes. 2007
Ma J, et al. Evaluation of the association between the common E469K polymorphism in the ICAM-1 gene and diabetic nephropathy among type 1 diabetic patients in GoKinD population. 2008
Penco S, et al. New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background. 2008
Fry AE, et al. Variation in the ICAM1 gene is not associated with severe malaria phenotypes. 2008
Dema B, et al. ICAM1 R241 is not associated with celiac disease in the Spanish population. 2008
Van Ness B, et al. Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival. 2008
Wang X, et al. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. 2009
Zee RY, et al. Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach. 2009
Conen D, et al. Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Women's Genome Health Study. 2009
Hindorff LA, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. 2009
Schürks M, et al. A candidate gene association study of 77 polymorphisms in migraine. 2009
Lynch AI, et al. Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study. 2012
Yilmaz U, et al. Investigation of ICAM-1 and β3 integrin gene variations in patients with brain tumors. 2015
Fletcher O, et al. Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls. 2010
Cox A, et al. A common coding variant in CASP8 is associated with breast cancer risk. 2007
Ye C, et al. Two-stage case-control study of common ATM gene variants in relation to breast cancer risk. 2007
Grochola LF, et al. Single-nucleotide polymorphisms in the p53 signaling pathway. 2010
Travis RC, et al. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. 7610
Johnson N, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. 2007
Fletcher O, et al. Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls. 2010
Einarsdóttir K, et al. Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study. 2015
Edvardsen H, et al. Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence. 2007
Concannon P, et al. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. 2008
Johnson N, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. 2007
Fletcher O, et al. Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls. 2010
Xu L, et al. Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma. 2012
Einarsdóttir K, et al. Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study. 2015
Edvardsen H, et al. Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence. 2007
Concannon P, et al. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. 2008
Milne RL, et al. Variants in the ATM gene and breast cancer susceptibility. 2009
Pugh TJ, et al. Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patients. 2009
Henríquez-Hernández LA, et al. Polymorphisms in DNA-repair genes in a cohort of prostate cancer patients from different areas in Spain: heterogeneity between populations as a confounding factor in association studies. 2013
Johnson N, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. 2007
Fletcher O, et al. Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls. 2010
Einarsdóttir K, et al. Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study. 2015
Ye C, et al. Two-stage case-control study of common ATM gene variants in relation to breast cancer risk. 2007
Edvardsen H, et al. Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence. 2007
Concannon P, et al. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. 2008
Modi WS, et al. Haplotype analysis of the SDF-1 (CXCL12) gene in a longitudinal HIV-1/AIDS cohort study. 2005
Shen W, et al. CXCL12 G801A polymorphism and breast cancer risk: a meta-analysis. 2012
Garcia-Moruja C, et al. Molecular phenotype of CXCL12beta 3'UTR G801A polymorphism (rs1801157) associated to HIV-1 disease progression. 2009
Maley SN, et al. Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study. 2009
Luan B, et al. Association of the SDF1-3'A polymorphism with susceptibility to myocardial infarction in Chinese Han population. 2010
de Oliveira KB, et al. CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma. 2015
Kruszyna Ł, et al. CXCL12-3' G801A polymorphism is not a risk factor for breast cancer. 2010
Mrowicki J, et al. Association of the-801G/A polymorphism of CXCL12 gene with the risk of inflammatory bowel diseases development in a Polish population. 2011
de Oliveira KB, et al. CXCL12, CXCR4 and IFNγ genes expression: implications for proinflammatory microenvironment of breast cancer. 2013
Hoffjan S, et al. Gene-environment interaction effects on the development of immune responses in the 1st year of life. 2005
Cerhan JR, et al. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. 2007
Nejentsev S, et al. Sequencing and association analysis of the type 1 diabetes-linked region on chromosome 10p12-q11. 2007
Colobran R, et al. The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and configure intricate patterns of disease susceptibility. 2007
Hidalgo-Pascual M, et al. Analysis of CXCL12 3'UTR G>A polymorphism in colorectal cancer. 2007
Habermann TM, et al. Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era. 2008
Colt JS, et al. Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma. 2009
Xiao Q, et al. SDF1 gene variation is associated with circulating SDF1alpha level and endothelial progenitor cell number: the Bruneck Study. 2008
Wang X, et al. A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. 2009
Lin GT, et al. Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. 2009
Zee RY, et al. Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach. 2009
Chang CC, et al. Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. 2015
Conen D, et al. Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Women's Genome Health Study. 2009
Schürks M, et al. A candidate gene association study of 77 polymorphisms in migraine. 2009
Brown WM, et al. Overview of the Rapid Response data. 2009
Julier C, et al. The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome. 2009
Fellay J, et al. Common genetic variation and the control of HIV-1 in humans. 2009
Levine AJ, et al. CCL3 genotype and current depression increase risk of HIV-associated dementia. 2009
Wang B, et al. Haplotype analysis of chemokine CXCL12 polymorphisms and susceptibility to premature ovarian failure in Chinese women. 2011
Lee JP, et al. Genetic predisposition of donors affects the allograft outcome in kidney transplantation; polymorphisms of stromal-derived factor-1 and CXC receptor 4. 2011
Schimanski CC, et al. SNP rs1801157 significantly correlates with distant metastasis in CXCL12 expressing esophagogastric cancer. 2011
de Oliveira KB, et al. CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients. 2011
Gianesin K, et al. The role of genetic variants of Stromal cell-Derived Factor 1 in pediatric HIV-1 infection and disease progression. 2012
Ku FC, et al. Stromal-derived factor-1 gene variations in pediatric patients with primary immune thrombocytopenia. 2013
de Lourdes Perim A, et al. CXCL12 and TP53 genetic polymorphisms as markers of susceptibility in a Brazilian children population with acute lymphoblastic leukemia (ALL). 2013
Mazur G, et al. The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma. 2013
Gong H, et al. The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies. 2012
Feng L, et al. A single nucleotide polymorphism in the stromal cell-derived factor 1 gene is associated with coronary heart disease in Chinese patients. 2014
Wang CJ, et al. Stromal cell-derived factor 1 gene polymorphism is associated with susceptibility to adverse long-term allograft outcomes in non-diabetic kidney transplant recipients. 2014
Casadei S, et al. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. 2011
Wong MW, et al. BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer. 2011
Tischkowitz M, et al. Analysis of PALB2/FANCN-associated breast cancer families. 2007
Cao AY, et al. The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. 2009
Casadei S, et al. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. 2011
Peterlongo P, et al. PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer. 2011
Cao AY, et al. The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. 2009
Rahman N, et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. 2007
García MJ, et al. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families. 2009
Bogdanova N, et al. PALB2 mutations in German and Russian patients with bilateral breast cancer. 2011
Casadei S, et al. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. 2011
Erkko H, et al. A recurrent mutation in PALB2 in Finnish cancer families. 2007
Erkko H, et al. Penetrance analysis of the PALB2 c.1592delT founder mutation. 2008
Heikkinen T, et al. The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype. 2009
Bogdanova N, et al. PALB2 mutations in German and Russian patients with bilateral breast cancer. 2011
Papi L, et al. A PALB2 germline mutation associated with hereditary breast cancer in Italy. 2010
Foulkes WD, et al. Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. 2015
Ghadirian P, et al. The contribution of founder mutations to early-onset breast cancer in French-Canadian women. 2009
Rahman N, et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. 2007
Casadei S, et al. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. 2011
Reid S, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. 2007
Casadei S, et al. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. 2011
Casadei S, et al. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. 2011
Bogdanova N, et al. PALB2 mutations in German and Russian patients with bilateral breast cancer. 2011
Casadei S, et al. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. 2011
Rahman N, et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. 2007
Johnson N, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. 2007
Hartmaier RJ, et al. Nuclear receptor coregulator SNP discovery and impact on breast cancer risk. 2009
Englund A, et al. NPAS2 and PER2 are linked to risk factors of the metabolic syndrome. 2009
Sjöholm LK, et al. CLOCK is suggested to associate with comorbid alcohol use and depressive disorders. 2010
Kaklamani VG, et al. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. 2008
Beckers S, et al. Association study and mutation analysis of adiponectin shows association of variants in APM1 with complex obesity in women. 2009
Sharma A, et al. Low serum adiponectin levels are associated with systemic organ failure in acute pancreatitis. 2009
Wang Y, et al. Association study of the single nucleotide polymorphisms in adiponectin-associated genes with type 2 diabetes in Han Chinese. 2009
Fang WL, et al. Analysis of adiponectin gene polymorphisms in Chinese population with systemic lupus erythematosus. 2010
Chiodini BD, et al. Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population. 2010
Youpeng B, et al. Relationships among adiponectin gene polymorphisms, proteinuria and increased blood pressure in the context of placental diseases. 2010
Kaklamani V, et al. Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. 2011
Nyante SJ, et al. Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes. 2011
Cui E, et al. The role of adiponectin (ADIPOQ) gene polymorphisms in the susceptibility and prognosis of non-small cell lung cancer. 2011
Lee JY, et al. Genetic effects of adiponectin single nucleotide polymorphisms on the clustering of metabolic risk factors in young Korean adults. 2012
Ranjzad F, et al. A common variant in the adiponectin gene and polycystic ovary syndrome risk. 2012
Zhang BC, et al. A meta-analysis of the association of adiponectin gene polymorphisms with coronary heart disease in Chinese Han population. 2012
Oliveira CS, et al. Association of ADIPOQ variants, total and high molecular weight adiponectin levels with coronary artery disease in diabetic and non-diabetic Brazilian subjects. 2012
Wang B, et al. An association study of SNP + 45 T > G of the AdipoQ gene with type 2 diabetes in Yi and Han people in China. 2011
Xi B, et al. Common polymorphisms (rs2241766 and rs1501299) in the ADIPOQ gene are not associated with hypertension susceptibility among the Chinese. 2012
Pollin TI, et al. Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. 2005
Hegener HH, et al. Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: a nested case-control study. 2006
Ahituv N, et al. Medical sequencing at the extremes of human body mass. 2007
Pischon T, et al. Single nucleotide polymorphisms at the adiponectin locus and risk of coronary heart disease in men and women. 2007
Kyriakou T, et al. Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity. 2008
Potapov VA, et al. Adiponectin and adiponectin receptor gene variants in relation to type 2 diabetes and insulin resistance-related phenotypes. 2008
Simoni M, et al. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. 2008
Pérez-Martínez P, et al. Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men. 2008
Hivert MF, et al. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. 2008
Kaklamani VG, et al. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. 2008
Moore SC, et al. Adipokine genes and prostate cancer risk. 2009
Rasmussen-Torvik LJ, et al. The association of SNPs in ADIPOQ, ADIPOR1, and ADIPOR2 with insulin sensitivity in a cohort of adolescents and their parents. 2009
Warodomwichit D, et al. ADIPOQ polymorphisms, monounsaturated fatty acids, and obesity risk: the GOLDN study. 2009
Chang YC, et al. Interaction of ADIPOQ genetic polymorphism with blood pressure and plasma cholesterol level on the risk of coronary artery disease. 2009
Melistas L, et al. Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women. 2009
Martinez-Gomez D, et al. Design and evaluation of a treatment programme for Spanish adolescents with overweight and obesity. The EVASYON Study. 2009
Khabour OF, et al. Associations of polymorphisms in adiponectin and leptin genes with men's longevity. 2010
Chen Y, et al. Analysis of adiponectin gene polymorphisms in dilated cardiomyopathy in a Han Chinese population. 2010
Liu F, et al. Association of adiponectin gene polymorphisms with the risk of ischemic stroke in a Chinese Han population. 2011
Zhao T, et al. Genetic effects of adiponectin on blood lipids and blood pressure. 2011
Siitonen N, et al. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. 2011
Masson S, et al. Adiponectin in chronic heart failure: influence of diabetes and genetic variants. 2011
Han LY, et al. Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. 2011
Gueuvoghlanian-Silva BY, et al. Profile of inflammatory mediators in gestational diabetes mellitus: phenotype and genotype. 2012
Yang Y, et al. Association of ADIPOQ gene polymorphisms and coronary artery disease risk: a meta-analysis based on 12 465 subjects. 2012
Jing C, et al. Meta-analysis of association studies between five candidate genes and type 2 diabetes in Chinese Han population. 2012
Gupta V, et al. Association of TCF7L2 and ADIPOQ with body mass index, waist-hip ratio, and systolic blood pressure in an endogamous ethnic group of India. 2012
Antonopoulos AS, et al. Genetic variability on adiponectin gene affects myocardial infarction risk: the role of endothelial dysfunction. 2013
Guzman-Ornelas MO, et al. Association of ADIPOQ +45T>G polymorphism with body fat mass and blood levels of soluble adiponectin and inflammation markers in a Mexican-Mestizo population. 2012
Zhou W, et al. Adiponectin (ADIPOQ) rs2241766 G/T polymorphism is associated with risk of cancer: evidence from a meta-analysis. 2013
Udomsinprasert W, et al. +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with the susceptibility to biliary atresia. 2012
Yang Y, et al. ADIPOQ gene polymorphisms and cancer risk: a meta-analysis. 2013
Ye Y, et al. Adiponectin gene polymorphisms may not be associated with idiopathic premature ovarian failure. 2013
Chu H, et al. AdipoQ polymorphisms are associated with type 2 diabetes mellitus: a meta-analysis study. 2013
Alsaleh A, et al. Adiponectin gene variant interacts with fish oil supplementation to influence serum adiponectin in older individuals. 2013
Cai X, et al. The adiponectin gene single-nucleotide polymorphism rs1501299 is associated with hepatocellular carcinoma risk. 2014
Machado JS, et al. Polymorphisms of the adiponectin gene in gestational hypertension and pre-eclampsia. 2014
Choe EY, et al. Variants of the adiponectin gene and diabetic microvascular complications in patients with type 2 diabetes. 2013
Xu J, et al. [Association of adiponectin gene polymorphrism with metabolic syndrome in older Han adults from major cities in China]. 2013
Gherman CD, et al. Association of atherosclerotic peripheral arterial disease with adiponectin genes SNP+45 and SNP+276: a case-control study. 2013
Hu X, et al. Gene Polymorphisms of ADIPOQ +45T>G, UCP2 -866G>A, and FABP2 Ala54Thr on the Risk of Colorectal Cancer: A Matched Case-Control Study. 2013
Zhou D, et al. Association between the adiponectin +45T>G genotype and risk of cardiovascular disease: a meta-analysis. 2014
Li P, et al. An updated meta-analysis of the association between ADIPOQ rs2241766 polymorphism and colorectal cancer. 2014
Zhang W, et al. Family-based analysis of adiponectin gene polymorphisms in Chinese Han polycystic ovary syndrome. 2014
Xu Y, et al. The roles of ADIPOQ genetic variations in cancer risk: evidence from published studies. 2013
Lee Y, et al. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study. 2013
Denlinger LC, et al. P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy. 2013
Kong KA, et al. Association of adiponectin gene polymorphism with birth weight in Korean neonates. 2013
Chung HF, et al. Adiponectin gene (ADIPOQ) polymorphisms correlate with the progression of nephropathy in Taiwanese male patients with type 2 diabetes. 2014
Li P, et al. Correlation of serum adiponectin and adiponectin gene polymorphism with metabolic syndrome in Chinese adolescents. 2015
Tu Y, et al. Assessment of type 2 diabetes risk conferred by SNPs rs2241766 and rs1501299 in the ADIPOQ gene, a case/control study combined with meta-analyses. 2014
Lu JF, et al. Association of ADIPOQ polymorphisms with obesity risk: a meta-analysis. 2014
Kelemen LE, et al. Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies. 2008
Couch FJ, et al. Association of breast cancer susceptibility variants with risk of pancreatic cancer. 2009
Dimasi DP, et al. Candidate gene study to investigate the genetic determinants of normal variation in central corneal thickness. 2010
Hunter DJ, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. 2007
Liang J, et al. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. 2008
Peng S, et al. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. 2011
Zhao ZZ, et al. Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk. 2008
Gold B, et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. 2008
Udler MS, et al. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. 2009
Zhu X, et al. Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer. 2009
Nan H, et al. Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study. 2009
Kawase T, et al. FGFR2 intronic polymorphisms interact with reproductive risk factors of breast cancer: results of a case control study in Japan. 2009
Zhong H, et al. Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases. 2010
Zhang J, et al. Current evidence on the relationship between three polymorphisms in the FGFR2 gene and breast cancer risk: a meta-analysis. 2010
Jia C, et al. Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer. 2010
Barnholtz-Sloan JS, et al. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. 2010
Jara L, et al. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population. 2013
Liu CL, et al. Case-control study on the fibroblast growth factor receptor 2 gene polymorphisms associated with breast cancer in chinese han women. 2013
Wang H, et al. Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk. 2013
Hsieh SM, et al. Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study. 1863
Hsieh SM, et al. Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study. 1863
Gaudet MM, et al. Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis. 2009
Xie C, et al. Sipa1 promoter polymorphism predicts risk and metastasis of lung cancer in Chinese. 2013
Leach AB, et al. The Laryngeal Mask--an overview. 2015
Cao AY, et al. Five common single nucleotide polymorphisms in the PALB2 gene and susceptibility to breast cancer in eastern Chinese population. 2010
Dansonka-Mieszkowska A, et al. A novel germline PALB2 deletion in Polish breast and ovarian cancer patients. 2010
Blanco A, et al. Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases. 2013
Cao AY, et al. Five common single nucleotide polymorphisms in the PALB2 gene and susceptibility to breast cancer in eastern Chinese population. 2010
Chen P, et al. Association of common PALB2 polymorphisms with breast cancer risk: a case-control study. 2008
Dansonka-Mieszkowska A, et al. A novel germline PALB2 deletion in Polish breast and ovarian cancer patients. 2010
Cross-Disorder Group of the Psychiatric Genomics Consortium, et al. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. 2013
Loizidou MA, et al. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. 2008
Burri RJ, et al. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. 2008
Xue H, et al. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis. 2011
Pan QH, et al. [Family-based association study of XRCC1 gene polymorphisms in nasopharyngeal carcinoma]. 2007
Coppedè F, et al. Association study between XRCC1 gene polymorphisms and sporadic amyotrophic lateral sclerosis. 2015
Gugatschka M, et al. DNA repair gene ERCC2 polymorphisms and risk of squamous cell carcinoma of the head and neck. 2011
Sigurdson AJ, et al. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. 2004
van der Straaten T, et al. Multiplex pyrosequencing of two polymorphisms in DNA repair gene XRCC1. 2006
Sak SC, et al. DNA repair gene XRCC1 polymorphisms and bladder cancer risk. 2007
Huang WY, et al. Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China. 2008
Zhu Y, et al. Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools. 2008
Rosenberger A, et al. Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years. 2008
McWilliams RR, et al. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. 2008
Dai Z, et al. Genotyping panel for assessing response to cancer chemotherapy. 2008
Smith TR, et al. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. 2008
Chang MH, et al. Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. 2009
Hung RJ, et al. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. 2008
Chang JS, et al. Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. 2009
Sigurdson AJ, et al. Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. 2009
Applebaum KM, et al. Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma. 2009
Li Y, et al. Gene-environment interactions between DNA repair polymorphisms and exposure to the carcinogen vinyl chloride. 2009
Chang-Claude J, et al. Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. 2009
Zipprich J, et al. XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study. 2010
Yin M, et al. Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. 2011
Osorio A, et al. Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. 2011
Santonocito C, et al. Polymorphisms in base excision DNA repair genes and association with melanoma risk in a pilot study on Central-South Italian population. 2012
Henríquez-Hernández LA, et al. Polymorphisms in DNA-repair genes in a cohort of prostate cancer patients from different areas in Spain: heterogeneity between populations as a confounding factor in association studies. 2013
Henríquez-Hernández LA, et al. High-throughput genotyping system as a robust and useful tool in oncology: experience from a single institution. 2013
Adel Fahmideh M, et al. Association between DNA repair gene polymorphisms and risk of glioma: a systematic review and meta-analysis. 2014
Liu L, et al. Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies. 2013
Li SX, et al. [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma]. 2014
Skarpengland T, et al. Genetic variants in the DNA repair gene NEIL3 and the risk of myocardial infarction in a nested case-control study. The HUNT Study. 2015
Akhmadishina LZ, et al. [DNA repair XRCC1, XPD genes polymorphism as associated with the development of bladder cancer and renal cell carcinoma]. 2014
Peelen T, et al. Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families. 2000
Green RC, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. 2013
Stacey SN, et al. The BARD1 Cys557Ser variant and breast cancer risk in Iceland. 2006
Gonzalez-Hormazabal P, et al. The BARD1 Cys557Ser variant and risk of familial breast cancer in a South-American population. 2012
Capasso M, et al. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. 2009
van Schijndel JE, et al. Three-cohort targeted gene screening reveals a non-synonymous TRKA polymorphism associated with schizophrenia. 2009
Hunter DJ, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. 2007
Huijts PE, et al. Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10. 2011
Chen F, et al. Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality. 2012
Lin CY, et al. Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer. 2012
Huo D, et al. Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. 2012
Zhao ZZ, et al. Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk. 2008
Meyer KB, et al. Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. 2008
Udler MS, et al. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. 2009
Lee W, et al. Analytical methods for inferring functional effects of single base pair substitutions in human cancers. 2009
Zhu X, et al. Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer. 2009
Robbez-Masson LJ, et al. Functional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing. 2013
Zhou L, et al. Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis. 2012
Low SK, et al. Genome-wide association study of breast cancer in the Japanese population. 2013
Hunter DJ, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. 2007
Thomas G, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). 2009
Turnbull C, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. 2010
Peng S, et al. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. 2011
Zhao ZZ, et al. Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk. 2008
Gold B, et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. 2008
Zhu X, et al. Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer. 2009
Nan H, et al. Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study. 2009
Barnholtz-Sloan JS, et al. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. 2010
Sueta A, et al. A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population. 2012
Michailidou K, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. 2013
Liu CL, et al. Case-control study on the fibroblast growth factor receptor 2 gene polymorphisms associated with breast cancer in chinese han women. 2013
Chan M, et al. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population. 2012
Zhou L, et al. Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis. 2012
Tchatchou S, et al. Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity. 2010
Tchatchou S, et al. Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activity. 2010
Gao C, et al. Identifying breast cancer risk loci by global differential allele-specific expression (DASE) analysis in mammary epithelial transcriptome. 2012
Driver KE, et al. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. 2008
Melzer D, et al. A common variant of the p16(INK4a) genetic region is associated with physical function in older people. 2007
Mavaddat N, et al. Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. 2009
Goode EL, et al. Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. 2009
Driver KE, et al. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. 2008
Melzer D, et al. A common variant of the p16(INK4a) genetic region is associated with physical function in older people. 2007
Goode EL, et al. Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. 2009
Cunnington MS, et al. Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. 2010
Loizidou MA, et al. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. 2008
Auranen A, et al. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. 2005
Curtin K, et al. Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis. 2009
Yu KD, et al. XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37,369 subjects. 2010
Lin WY, et al. A role for XRCC2 gene polymorphisms in breast cancer risk and survival. 2011
Fayaz S, et al. Assessment of genetic mutations in the XRCC2 coding region by high resolution melting curve analysis and the risk of differentiated thyroid carcinoma in Iran. 2012
Wu X, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. 2006
Hill DA, et al. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. 2006
Figueroa JD, et al. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. 2007
Beesley J, et al. Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set. 2007
Zhu Y, et al. Correlating observed odds ratios from lung cancer case-control studies to SNP functional scores predicted by bioinformatic tools. 2008
Margulis V, et al. Genetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway. 2008
Hung RJ, et al. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. 2008
Pooley KA, et al. Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk. 2008
Mavaddat N, et al. Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. 2009
Pearce CL, et al. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. 2009
Sehl ME, et al. Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer. 2009
Chang-Claude J, et al. Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. 2009
Quaye L, et al. Association between common germline genetic variation in 94 candidate genes or regions and risks of invasive epithelial ovarian cancer. 2009
Silva SN, et al. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51. 2010
Krupa R, et al. Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer--a case control study. 2011
Reeves SG, et al. DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome. 2012
Pérez LO, et al. XRCC2 R188H (rs3218536), XRCC3 T241M (rs861539) and R243H (rs77381814) single nucleotide polymorphisms in cervical cancer risk. 2013
He Y, et al. Impact of XRCC2 Arg188His polymorphism on cancer susceptibility: a meta-analysis. 2014
Driver KE, et al. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. 2008
Chang BL, et al. A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer. 2004
Cai H, et al. Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among Chinese women. 2011
Landa I, et al. Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels. 2010
Wu X, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. 2006
Melzer D, et al. A common variant of the p16(INK4a) genetic region is associated with physical function in older people. 2007
Harris SE, et al. A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition. 2007
Wang W, et al. Genetic variants in cell cycle control pathway confer susceptibility to lung cancer. 2007
Mavaddat N, et al. Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. 2009
Goode EL, et al. Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. 2009
van Tiel CM, et al. p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity. 2009
Grochola LF, et al. Single-nucleotide polymorphisms in the p53 signaling pathway. 2010
Yang W, et al. Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians. 2013
Driver KE, et al. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. 2008
Goode EL, et al. Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. 2009
Melzer D, et al. A common variant of the p16(INK4a) genetic region is associated with physical function in older people. 2007
Mavaddat N, et al. Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer. 2009
Suarez BK, et al. A search for non-chromosome 6 susceptibility loci contributing to rheumatoid arthritis. 2009
Cunnington MS, et al. Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. 2010
Gu F, et al. Common genetic variants in the 9p21 region and their associations with multiple tumours. 2013
Li WQ, et al. Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers. 2014
Zhang J, et al. B7-H4 gene polymorphisms are associated with sporadic breast cancer in a Chinese Han population. 2009
Ozgöz A, et al. An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer. 2013
Prentice RL, et al. Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. 2009
Prentice RL, et al. Variation in the FGFR2 gene and the effect of a low-fat dietary pattern on invasive breast cancer. 2010
Huang Y, et al. Genetic variants in the MRPS30 region and postmenopausal breast cancer risk. 2011
Campa D, et al. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. 2011
Chen F, et al. Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality. 2012
Zhao ZZ, et al. Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk. 2008
Elgazzar S, et al. A genome-wide association study identifies a genetic variant in the SIAH2 locus associated with hormonal receptor-positive breast cancer in Japanese. 2012
Easton DF, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. 2007
Stacey SN, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. 2007
Huijts PE, et al. Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases. 2300
Garcia-Closas M, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. 2008
Mcinerney N, et al. Low penetrance breast cancer predisposition SNPs are site specific. 2009
Stacey SN, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. 2007
Thomas G, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). 2009
Ruiz-Narváez EA, et al. Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women. 2010
Turnbull C, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. 2010
Reeves GK, et al. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci. 2010
Tamimi RM, et al. Birth weight, breast cancer susceptibility loci, and breast cancer risk. 2010
Long J, et al. Evaluation of breast cancer susceptibility loci in Chinese women. 2010
Chen MB, et al. Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects. 2011
Li J, et al. A combined analysis of genome-wide association studies in breast cancer. 2011
Jiang Y, et al. Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province. 2011
Han W, et al. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype. 2011
Peng S, et al. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. 2011
Slattery ML, et al. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States. 2011
Riaz M, et al. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes. 2012
Campa D, et al. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. 2011
Hutter CM, et al. Replication of breast cancer GWAS susceptibility loci in the Women's Health Initiative African American SHARe Study. 2011
Fanale D, et al. Breast cancer genome-wide association studies: there is strength in numbers. 2012
Kim HC, et al. A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study. 2012
Gold B, et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. 2008
Gail MH, et al. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. 2008
Tamimi RM, et al. Breast cancer susceptibility loci and mammographic density. 2008
Bhatti P, et al. Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists. 2008
Kelemen LE, et al. Can genes for mammographic density inform cancer aetiology? 2008
McGrath M, et al. Novel breast cancer risk alleles and endometrial cancer risk. 2008
Gates MA, et al. Breast cancer susceptibility alleles and ovarian cancer risk in 2 study populations. 2009
Garcia-Closas M, et al. Genetic susceptibility loci for breast cancer by estrogen receptor status. 2008
Tapper W, et al. The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer. 2008
Zheng W, et al. Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. 2009
Woolcott CG, et al. Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort. 2009
Song H, et al. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. 2009
Kelemen LE, et al. Genetic variation in the chromosome 17q23 amplicon and breast cancer risk. 2009
Milne RL, et al. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. 2009
Yang Q, et al. Using lifetime risk estimates in personal genomic profiles: estimation of uncertainty. 2009
Zaitlen N, et al. Leveraging genetic variability across populations for the identification of causal variants. 2010
Mavaddat N, et al. Familial relative risks for breast cancer by pathological subtype: a population-based cohort study. 2010
Liang J, et al. Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population. 2010
Wacholder S, et al. Performance of common genetic variants in breast-cancer risk models. 2010
Zheng W, et al. Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. 2010
Long J, et al. Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. 2010
Travis RC, et al. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. 7610
Chen W, et al. Association between rs3803662 polymorphism of trinucleotide repeat containing 9 gene and breast cancer risk. 2011
Broeks A, et al. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. 2011
Stevens KN, et al. Common breast cancer susceptibility loci are associated with triple-negative breast cancer. 2011
Harlid S, et al. Combined effect of low-penetrant SNPs on breast cancer risk. 2012
Sueta A, et al. A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population. 2012
Fasching PA, et al. The role of genetic breast cancer susceptibility variants as prognostic factors. 2012
Gudmundsdottir ET, et al. The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients. 2012
Orr N, et al. Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. 2012
Barzan D, et al. Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations. 2013
Sapkota Y, et al. Identification of a breast cancer susceptibility locus at 4q31.22 using a genome-wide association study paradigm. 2013
Mizoo T, et al. Effects of lifestyle and single nucleotide polymorphisms on breast cancer risk: a case-control study in Japanese women. 2013
Garcia-Closas M, et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. 2013
Michailidou K, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. 2013
Shan J, et al. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians. 2012
Liu J, et al. Associations between single-nucleotide polymorphisms and epidural ropivacaine consumption in patients undergoing breast cancer surgery. 2013
Low SK, et al. Genome-wide association study of breast cancer in the Japanese population. 2013
Park SL, et al. Association of cancer susceptibility variants with risk of multiple primary cancers: The population architecture using genomics and epidemiology study. 2014
Elematore I, et al. Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population. 2014
[PMID 25784121] Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography
Turnbull C, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. 2010
Long J, et al. Evaluation of breast cancer susceptibility loci in Chinese women. 2010
Antoniou AC, et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. 2010
Fletcher O, et al. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. 2011
Han W, et al. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype. 2011
Peng S, et al. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies. 2011
Campa D, et al. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. 2011
Lin CY, et al. Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer. 2012
Ahmed S, et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. 2009
Zhong H, et al. Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases. 2010
Mavaddat N, et al. Familial relative risks for breast cancer by pathological subtype: a population-based cohort study. 2010
Broeks A, et al. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. 2011
Sueta A, et al. A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population. 2012
Fasching PA, et al. The role of genetic breast cancer susceptibility variants as prognostic factors. 2012
Chen W, et al. The SLC4A7 variant rs4973768 is associated with breast cancer risk: evidence from a case-control study and a meta-analysis. 2012
Michailidou K, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. 2013
[PMID 25784121] Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography
Johnson N, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. 2007
Fletcher O, et al. Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls. 2010
Concannon P, et al. Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. 2008
Johnson N, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. 2007
Bhatti P, et al. Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologists. 2008
De Leeneer K, et al. Genotyping of frequent BRCA1/2 SNPs with unlabeled probes: a supplement to HRMCA mutation scanning, allowing the strong reduction of sequencing burden. 2009
Johnson N, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. 2007
Krupa R, et al. Association between polymorphisms of the BRCA2 gene and clinical parameters in breast cancer. 2009
Easton DF, et al. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. 2007
Onay UV, et al. Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk. 2008
Weinhold N, et al. The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. 2013
Wang Y, et al. Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case-control studies. 2014
Kaklamani VG, et al. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. 2008
Kaklamani VG, et al. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. 2008
Kaklamani V, et al. Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. 2011
Siitonen N, et al. Association of sequence variations in the gene encoding adiponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish Diabetes Prevention Study. 2006
Richardson DK, et al. Association between variants in the genes for adiponectin and its receptors with insulin resistance syndrome (IRS)-related phenotypes in Mexican Americans. 2006
Collins SC, et al. Adiponectin receptor genes: mutation screening in syndromes of insulin resistance and association studies for type 2 diabetes and metabolic traits in UK populations. 2007
Kaklamani VG, et al. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. 2008
Rasmussen-Torvik LJ, et al. The association of SNPs in ADIPOQ, ADIPOR1, and ADIPOR2 with insulin sensitivity in a cohort of adolescents and their parents. 2009
Johnson N, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. 2007
Hill DA, et al. Risk of non-Hodgkin lymphoma (NHL) in relation to germline variation in DNA repair and related genes. 2006
Hunter DJ, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. 2007
Boyarskikh UA, et al. Association of FGFR2 gene polymorphisms with the risk of breast cancer in population of West Siberia. 2009
Meyer KB, et al. Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. 2008
Udler MS, et al. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. 2009
Lee W, et al. Analytical methods for inferring functional effects of single base pair substitutions in human cancers. 2009
Zhu X, et al. Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer. 2009
Rrp1B gene polymorphism (1307T>C) in metastatic progression of breast cancer
Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population
深圳市市场监督管理局企业主体身份公示
中文
English